Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
Line 568: | Line 568: | ||
|- | |- | ||
! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[High-molecular-weight kininogen|High molecular weight kininogen (HMWK)]] deficiency | ! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[High-molecular-weight kininogen|High molecular weight kininogen (HMWK)]] deficiency | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* | * Positive family history of bleeding | ||
| | | align="center" style="background:#F5F5F5;" | | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Prekallikrein]] deficiency | ! colspan="3" rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Prekallikrein]] deficiency | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* | * Positive family history of bleeding | ||
| | | align="center" style="background:#F5F5F5;" | | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor XIII deficiency]] | ! rowspan="1" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Factor XIII deficiency]] | ||
! colspan="2" | | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" | | ||
* Sub unit A mutation disease (more common) | * Sub unit A mutation disease (more common) | ||
* Sub unit B mutation disease | * Sub unit B mutation disease | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* | * Positive family history of bleeding | ||
|± | | align="center" style="background:#F5F5F5;" |± | ||
|± | | align="center" style="background:#F5F5F5;" |± | ||
|± | | align="center" style="background:#F5F5F5;" |± | ||
|± | | align="center" style="background:#F5F5F5;" |± | ||
|± | | align="center" style="background:#F5F5F5;" |± | ||
|± | | align="center" style="background:#F5F5F5;" |± | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl or ↑ | | align="center" style="background:#F5F5F5;" |Nl or ↑ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Impaired fibrin cross linking or clot dissolution | * Impaired fibrin cross-linking or clot dissolution | ||
* The severity of factor XIII deficiency bleeds can be different in different patients | * The severity of factor XIII deficiency bleeds can be different in different patients | ||
|- | |- | ||
! rowspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Hemophilia]] | ! rowspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Hemophilia]] | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type A deficiency | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type A deficiency | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Eeasy [[Bruise|bruising]] | * Eeasy [[Bruise|bruising]] | ||
* Inadequate clotting in [[trauma]] or mild injury | * Inadequate clotting in [[trauma]] or mild injury | ||
Line 630: | Line 629: | ||
* [[Epistaxis]] | * [[Epistaxis]] | ||
* [[Gingival bleeding]] | * [[Gingival bleeding]] | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type B deficiency | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type B deficiency | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Neonatal bleeding | * Neonatal bleeding | ||
* Trauma-related soft | * Trauma-related soft tissue hemorrhage | ||
* [[Hemarthrosis]] | * [[Hemarthrosis]] | ||
* [[Hematoma|Hematomas]] | * [[Hematoma|Hematomas]] | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|− | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type C deficiency | ! colspan="2" align="center" style="padding: 5px 5px; background: #DCDCDC;" |Type C deficiency | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* | * Positive family history | ||
* Bleeding after surgery or injury | * Bleeding after surgery or injury | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
|Rare | | align="center" style="background:#F5F5F5;" |Rare | ||
|Rare | | align="center" style="background:#F5F5F5;" |Rare | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subcategory | ||
Line 697: | Line 696: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rare diseases | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Rare diseases | ||
! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]] | ! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]] | ||
| align="left" style="background:#F5F5F5;" | | |||
* [[Trauma]] | * [[Trauma]] | ||
* Burn | * [[Burn]] | ||
* [[Crush injury]] | * [[Crush injury]] | ||
* [[Sepsis]] | * [[Sepsis]] | ||
Line 705: | Line 704: | ||
* Obstetric complication: abruption, amniotic fluid embolism | * Obstetric complication: abruption, amniotic fluid embolism | ||
* [[Hemolytic anemia]] | * [[Hemolytic anemia]] | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
|↓ | | align="center" style="background:#F5F5F5;" |↓ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
|- | |- | ||
! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Vitamin K Deficiency]] | ! colspan="3" align="center" style="padding: 5px 5px; background: #DCDCDC;" |[[Vitamin K Deficiency]] | ||
| align="left" style="background:#F5F5F5;" | | |||
* Bleeding after trauma | * Bleeding after trauma | ||
* [[Epistaxis]] | * [[Epistaxis]] | ||
Line 729: | Line 728: | ||
* Oozing from venipuncture sites | * Oozing from venipuncture sites | ||
* Easy [[Bruise|bruisability]] | * Easy [[Bruise|bruisability]] | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
| | | align="center" style="background:#F5F5F5;" |+ | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|↑ | | align="center" style="background:#F5F5F5;" |↑ | ||
|Nl or mildly prolonged | | align="center" style="background:#F5F5F5;" |Nl or mildly prolonged | ||
|Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| − | | align="center" style="background:#F5F5F5;" |− | ||
|} | |} | ||
==Different types of Von-Willebrand diseases== | |||
{| | {| | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Type of VWD | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Type of VWD |
Revision as of 17:15, 19 October 2018
Differential Diagnosis
Different causes of the bleeding disorders can be differentiated based on their clinical manifestation and laboratory findings.
These features have discussed in the below table:
Category | Subcategory | Disease | History | Clinical manifestation | Laboratory testing | Comments | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | ||||||
Platelet disorders | Thrombocytopenia | Infection-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |
Medications-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | Most important part of treatment is discontinuing of the medication. | |||
Heparin-Induced thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | ↑ | For more information click here: Heparin-induced thrombocytopenia. | |||
Immune Thrombocytopenic Purpura (ITP) |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Inherited Thrombocytopenia |
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Thrombotic Thrombocytopenic Purpura (TTP) | History of:
|
+ | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Hemolytic Uremic Syndrome | History of: | + | + | + | + | + | + | ↓ | ↑ | Nl | Nl | Nl | − | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Thromobcytosis | Iron deficiency anemia
Inflammatory diseases |
− | − | − | − | ± | ± | ↑ | Nl or ↑ | Nl | Nl | Nl | − | |||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | Glanzmann’s thrombasthenia |
|
+ | + | + | + | − | Rare | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |
Bernard-Soulier syndrome |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |||
Wiskott-Aldrich syndrome |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl | ||||
Platelet storage pool disorder: |
|
+ | + | + | + | − | − | Nl or ↓ | ↑ | Nl | Nl | Nl |
| |||
Acquired Disorders of Platelet Function |
|
+ | + | + | + | ± | ± | Nl or ↓ | ↑ | Nl | Nl | Nl | − | |||
Von Willebrand Disease |
|
+ | + | + | + | ± | ± | ↑ | Nl | ↑ | ↑ | Nl | See the table below for the details about different types. | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Vessel wall disorders | Metabolic and Inflammatory Disorders |
|
|
− | + | + | ± | − | − | Nl | Nl or ↑ | Nl | Nl | Nl | − | |
Inherited Disorders of the Vessel Wall |
|
− | + | + | ± | − | − | Nl | Nl or ↑ | Nl | Nl | Nl | − | |||
Coagulation factor disorders | Fibrinogen deficiency |
Different types of the fibrinogen disorders: |
|
− | − | + | + | ± | + | Nl | ↑ | ↑ | ↑ | ↑ |
| |
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Prothrombin deficiency |
|
− | + | + | + | + | + | Nl | Nl | ↑ | ↑ | ↑ | − | |||
Factor V deficiency |
|
− | − | + | + | + | + | Nl | ↑ | ↑ | ↑ | Nl |
| |||
Factor VII deficiency |
|
+ | + | + | Nl | ↑ | Nl | Nl |
| |||||||
Factor X deficiency |
|
+ | + | + | + | + | Nl | Nl | ↑ | ↑ | Nl | − | ||||
Factor XII deficiency |
|
− | − | − | − | − | Nl | Nl | Nl | ↑ | Nl | |||||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
High molecular weight kininogen (HMWK) deficiency |
|
− | − | − | − | − | Nl | Nl | Nl | ↑ | Nl | |||||
Prekallikrein deficiency |
|
− | − | − | − | − | Nl | Nl | Nl | ↑ | Nl | |||||
Factor XIII deficiency |
|
|
± | ± | ± | ± | ± | ± | Nl | Nl | Nl or ↑ | Nl | Nl |
| ||
Hemophilia | Type A deficiency |
|
− | − | − | + | + | + | Nl | Nl | Nl | ↑ | Nl | − | ||
Type B deficiency |
|
− | − | − | + | + | + | Nl | Nl | Nl | ↑ | Nl | − | |||
Type C deficiency |
|
− | − | − | + | Rare | Rare | Nl | Nl | Nl | ↑ | Nl | − | |||
Subcategory | Disease | History | Mucosal bleeding | Petechia | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Plt | BT | PT | PTT | TT | Comments | ||
Rare diseases | Disseminated Intravascular Coagulation |
|
+ | + | + | + | + | + | ↓ | ↑ | ↑ | ↑ | Nl | − | ||
Vitamin K Deficiency |
|
+ | − | + | + | + | + | Nl | ↑ | ↑ | Nl or mildly prolonged | Nl | − |
Different types of Von-Willebrand diseases
Type of VWD | Type of factor deficiency | Prevalence | Inheritance pattern | Clinical manifestations | VWF activity | RIPA | Factor VIII | |
---|---|---|---|---|---|---|---|---|
Type 1 | Quantitative/ partial | 60-70% | AD |
|
↓ | ↓ | ↓ | |
Type 2 | 2A | Qualitative | 10% | AD/AR |
|
↓ | ↓ | N or ↓ |
2B | Qualitative | 5% | AD |
|
↓ | ↑ | N or ↓ | |
2M | Qualitative | <1% | AD/AR |
|
↓ | ↓ | N or ↓ | |
2N | Qualitative | <1% | AR |
|
N | N | ↓ | |
Type 3 | Complete deficiency | 1-2% | AR |
|
Absent | ↓ | Low, 1-10% |
For more information on Von Willebrand disease, click here.
- ↑ Invalid
<ref>
tag; no text was provided for refs namedpmid28966616